Outcomes of Vitrectomy in Pediatric Retinal Detachment with Proliferative Vitreoretinopathy

Robert Rejdak, Dominika Nowakowska, Katarzyna Wrona, Ryszard Maciejewski, Anselm G Junemann, Katarzyna Nowomiejska, Robert Rejdak, Dominika Nowakowska, Katarzyna Wrona, Ryszard Maciejewski, Anselm G Junemann, Katarzyna Nowomiejska

Abstract

Aim: To report outcomes of pars plana vitrectomy (PPV) in pediatric retinal detachment (RD) with proliferative vitreoretinopathy (PVR), complications, factors influencing the final anatomical and functional results.

Methods: Retrospective consecutive case series of 14 eyes. Average postoperative follow-up period was 34 months.

Results: Mean age of patients was 10 years; eleven patients (79%) were males. The most common etiology was trauma (57%), the second-myopia (36%) and one case of uveitis (7%). At the day of presentation, the best-corrected visual acuity (BCVA) was worse than hand motion (50%); macula was detached in 86% of cases. Simultaneous PPV and phacoemulsification with intraocular lens (IOL) implantation were performed in 12 cases (86%). The most common endotamponade during PPV was silicone oil (93%). Anatomic reattachment was accomplished in 86% of cases. Final BCVA was equal or better than 0.1 in 50% of patients. The postoperative complications were found in 5 eyes (36%).

Conclusion: Complete PPV was allowed for anatomically reattached retina and preserved vision in pediatric complex RD with PVR. However, visual outcomes were not satisfactory. Preserving vision in children with RD is of great importance for their future motor and intellectual development. This trial is registered with ClinicalTrials.gov Identifier: NCT03208205.

References

    1. Meier P. Retinal detachment in children: differential diagnosis and current therapy. Klinische Monatsblätter für Augenheilkunde. 2008;225(9):779–790. doi: 10.1055/s-2008-1027515.
    1. Wang N.-K., Tsai C.-H., Chen Y.-P., et al. Pediatric rhegmatogenous retinal detachment in East Asians. Ophthalmology. 2005;112(11):1890–1895. doi: 10.1016/j.ophtha.2005.06.019.
    1. Ang A., Poulson A. V., Goodburn S. F., Richards A. J., Scott J. D., Snead M. P. Retinal detachment and prophylaxis in type 1 stickler syndrome. Ophthalmology. 2008;115(1):164–168. doi: 10.1016/j.ophtha.2007.03.059.
    1. Weinberg D. V., Lyon A. T., Greenwald M. J., Mets M. B. Rhegmatogenous retinal detachments in children: risk factors and surgical outcomes. Ophthalmology. 2003;110(9):1708–1713. doi: 10.1016/S0161-6420(03)00569-4.
    1. Butler T. K., Kiel A. W., Orr G. M. Anatomical and visual outcome of retinal detachment surgery in children. The British Journal of Ophthalmology. 2001;85(12):1437–1439. doi: 10.1136/bjo.85.12.1437.
    1. Moisseiev J., Vidne O., Treister G. Vitrectomy and silicone oil injection in pediatric patients. Retina. 1998;18(3):221–227. doi: 10.1097/00006982-199803000-00005.
    1. Hjelmeland L. M., Harvey A. K. Chapter 9 gliosis of the mammalian retina: migration and proliferation of retinal glia. Progress in Retinal Research. 1988;7:259–281. doi: 10.1016/0278-4327(88)90011-9.
    1. Wiedemann P., Yandiev Y., Hui Y.-N., Wang Y. Chapter 97—pathogenesis of proliferative vitreoretinopathy. Retina Fifth Edition. 2013;3:1640–1646. doi: 10.1016/B978-1-4557-0737-9.00097-7.
    1. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983;90(2):121–125.
    1. Cheema R. A., Al-Khars W., Al-Askar E., Amin Y. M. Pediatric retinal detachment in the Eastern Province of Saudi Arabia: experience of a tertiary care hospital. Annals of Saudi Medicine. 2009;29(5):361–364.
    1. Gangwar D. N., Dogra M. R., Jain I. S., Grewal S. P. Study of juvenile retinal detachment. Indian Journal of Ophthalmology. 1983;31:892–894.
    1. Soheilian M., Ramezani A., Malihi M., et al. Clinical features and surgical outcomes of pediatric rhegmatogenous retinal detachment. Retina. 2009;29(4):545–551. doi: 10.1097/IAE.0b013e318194fd1a.
    1. Zafar S. N., Qureshi N., Azad N., Khan A. Retinal detachment in paediatric patients. Journal of the College of Physicians and Surgeons–Pakistan. 2013;23(4):261–264.
    1. Asaminew T., Gelaw Y., Bekele S., Solomon B. Retinal detachment in Southwest Ethiopia: a hospital based prospective study. PLoS One. 2013;8(9, article e75693) doi: 10.1371/journal.pone.0075693.
    1. Gurler B., Coskun E., Öner V., Comez A., Erbagci I. Clinical characteristics and surgical outcomes of pediatric rhegmatogenous retinal detachment. International Ophthalmology. 2016;36(4):521–525. doi: 10.1007/s10792-015-0158-3.
    1. Errera M.-H., Liyanage S. E., Moya R., Wong S. C., Ezra E. Primary scleral buckling for pediatric rhegmatogenous retinal detachment. Retina. 2015;35(7):1441–1449. doi: 10.1097/IAE.0000000000000480.
    1. Peyman G. A., Cheema R., Conway M. D., Fang T. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina. 2000;20(5):554–555. doi: 10.1097/00006982-200005000-00024.
    1. Couch S. M., Bakri S. J. Use of triamcinolone during vitrectomy surgery to visualize membranes and vitreous. Clinical Ophthalmology. 2008;2(4):891–896. doi: 10.2147/opth.s3434.
    1. Sakamoto T., Miyazaki M., Hisatomi T., et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefe's Archive for Clinical and Experimental Ophthalmology. 2002;240(6):423–429. doi: 10.1007/s00417-002-0454-2.
    1. Enaida H., Hata Y., Ueno A., et al. Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases. Retina. 2003;23(6):764–770. doi: 10.1097/00006982-200312000-00003.
    1. Mańkowska A., Rejdak R., Oleszczuk A., et al. Decrease of the postoperative inflammatory reaction during pars plana vitrectomy (PPV) after administration of triamcinolone acetonide. Klinika Oczna. 2008;110(4–6):151–154.
    1. Jackson T. L., Johnston R. L., Donachie P. H. J., Williamson T. H., Sparrow J. M., Steel D. H. W. The Royal College of Ophthalmologists’ National Ophthalmology Database Study of Vitreoretinal Surgery. JAMA Ophthalmology. 2016;134(1):p. 79. doi: 10.1001/jamaophthalmol.2015.4587.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj